|Articles|February 1, 2011
- BioPharm International-02-01-2011
- Volume 24
- Issue 2
BioPharm International, February 2011 Issue (PDF)
The Quality Product Steward Model
Advertisement
Articles in this issue
over 14 years ago
The Quality Product Steward Model: The Genentech Approachover 14 years ago
An Economic Comparison of Three Cell Culture Techniquesover 14 years ago
The Powerful Lesson of the GSK–Whistleblower Caseover 14 years ago
Trends Toward Standardizationover 14 years ago
Congress to Scrutinize FDA Rules, Research Policiesover 14 years ago
What a Piece of Work is PharmaNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
